View in EDS

NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.

Saved in:
Bibliographic Details
Title: NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.
Authors: de Dios O; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Ramírez-González MA; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Gómez-Soria I; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Segura-Collar B; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Manosalva J; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Megías D; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., De Andrea CE; Department of Anatomy, Physiology and Pathology, Universidad de Navarra, Pamplona, Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Fernández-Rubio L; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain., Hernández-Laín A; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Neuropathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sepúlveda-Sánchez JM; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Hospital HM Sanchinarro, Centro Integral Oncologico Clara Campal, Madrid, Spain., Rodriguez-Ruiz ME; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain.; Department of Radiation Oncology, Clinica Universidad de Navarra, Pamplona, Navarra, Spain., Pérez-Núñez Á; Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Surgery, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain., Wainwright DA; Department of Neurological Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA., Gargini R; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sánchez-Gómez P; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Aug 30; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 30.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39214651
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Dios+O%22">de Dios O</searchLink>; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ramírez-González+MA%22">Ramírez-González MA</searchLink>; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-Soria+I%22">Gómez-Soria I</searchLink>; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Segura-Collar+B%22">Segura-Collar B</searchLink>; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Manosalva+J%22">Manosalva J</searchLink>; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Megías+D%22">Megías D</searchLink>; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22De+Andrea+CE%22">De Andrea CE</searchLink>; Department of Anatomy, Physiology and Pathology, Universidad de Navarra, Pamplona, Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández-Rubio+L%22">Fernández-Rubio L</searchLink>; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández-Laín+A%22">Hernández-Laín A</searchLink>; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Neuropathology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sepúlveda-Sánchez+JM%22">Sepúlveda-Sánchez JM</searchLink>; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Hospital HM Sanchinarro, Centro Integral Oncologico Clara Campal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Ruiz+ME%22">Rodriguez-Ruiz ME</searchLink>; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain.; Department of Radiation Oncology, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Núñez+Á%22">Pérez-Núñez Á</searchLink>; Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Surgery, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Wainwright+DA%22">Wainwright DA</searchLink>; Department of Neurological Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Gargini+R%22">Gargini R</searchLink>; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Gómez+P%22">Sánchez-Gómez P</searchLink>; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2024 Aug 30; Vol. 12 (8). <i>Date of Electronic Publication: </i>2024 Aug 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39214651
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-009210
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Dios O
      – PersonEntity:
          Name:
            NameFull: Ramírez-González MA
      – PersonEntity:
          Name:
            NameFull: Gómez-Soria I
      – PersonEntity:
          Name:
            NameFull: Segura-Collar B
      – PersonEntity:
          Name:
            NameFull: Manosalva J
      – PersonEntity:
          Name:
            NameFull: Megías D
      – PersonEntity:
          Name:
            NameFull: De Andrea CE
      – PersonEntity:
          Name:
            NameFull: Fernández-Rubio L
      – PersonEntity:
          Name:
            NameFull: Hernández-Laín A
      – PersonEntity:
          Name:
            NameFull: Sepúlveda-Sánchez JM
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Ruiz ME
      – PersonEntity:
          Name:
            NameFull: Pérez-Núñez Á
      – PersonEntity:
          Name:
            NameFull: Wainwright DA
      – PersonEntity:
          Name:
            NameFull: Gargini R
      – PersonEntity:
          Name:
            NameFull: Sánchez-Gómez P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 08
              Text: 2024 Aug 30
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1